Ibm Retirement Fund Charles River Laboratories International, Inc. Transaction History

Ibm Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$204.13 - $302.4 $161,670 - $239,500	-792 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$255.51 - $362.11 $9,453 - $13,398	-37 Reduced 4.46%	792 $225,000
Q4 2021 Jan 19, 2022	SELL	$351.38 - $448.68 $205,908 - $262,926	-586 Reduced 41.41%	829 $312,000
Q3 2021 Oct 05, 2021	BUY	$372.64 - $458.3 $3,726 - $4,583	10 Added 0.71%	1,415 $584,000
Q2 2021 Jul 12, 2021	SELL	$294.17 - $371.65 $74,130 - $93,655	-252 Reduced 15.21%	1,405 $520,000
Q1 2021 Apr 22, 2021	SELL	$249.67 - $299.48 $36,451 - $43,724	-146 Reduced 8.1%	1,657 $480,000
Q4 2020 Jan 25, 2021	BUY	$222.0 - $252.62 $47,952 - $54,565	216 Added 13.61%	1,803 $450,000
Q3 2020 Oct 16, 2020	BUY	$175.56 - $226.45 $278,613 - $359,376	1,587 New	1,587 $359,000

720

51.9M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.